Legal Opinion
Degulis v. LXR Biotechnology, Inc.
District Court, S.D. New York
Decided June 6, 1996No. 95 Civ. 4204 (RWS), 95 Civ. 4299 (RWS), 95 Civ. 4298 (RWS), 95 Civ. 6422 (RWS) and 95 Civ. 7215 (RWS)PublishedCited by 36 opinions
1Opinion of the Court
OPINION
SWEET, District Judge.
Defendants in four related eases arising under Sections 11, 12(2) and 15 of the Securities Act of 1933 (the “Securities Act”), 15 U.S.C. §§ 77k(a), I'll (a)(2), 77o, and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), 15 U.S.C. §§ 78j(b), 78t(a), have moved to dismiss the claims against them pursuant to Federal Rule of Civil Procedure Rule 9(b) on the ground that the Complaints fail to plead fraud with particularity, and pursuant to Federal Rule of Civil Procedure 12(b)(6), on the ground that the Complaints fail to state a…
2Cases cited51 opinions
- TSC Industries, Inc. v. Northway, Inc.Supreme Court of the United States · 1976
- Herman & MacLean v. HuddlestonSupreme Court of the United States · 1983
- Pinter v. DahlSupreme Court of the United States · 1988
- Goldman v. BeldenCourt of Appeals for the Second Circuit · 1985
- Acito v. IMCERA Group, Inc.Court of Appeals for the Second Circuit · 1995
46 more not listed; retrieve them via the Exa API.
3Cited by36 opinions
- In Re Initial Public Offering Securities LitigationDistrict Court, S.D. New York · 2003
- Pinney v. Nokia, Inc.Court of Appeals for the Fourth Circuit · 2005
- In Re Global Crossing, Ltd. Securities LitigationDistrict Court, S.D. New York · 2004
- In re Oxford Health Plans, Inc.District Court, S.D. New York · 1999
- In Re Enron Corp. Securities, Derivative & ERISA Lit.District Court, S.D. Texas · 2002
31 more not listed; retrieve them via the Exa API.